Stockscreener 앱 받기
2.329
8.33%
0.179
시간 외 거래:
2.33
0.0010
+0.04%
Evoke Pharma Inc 주식(EVOK)의 최신 뉴스
StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World
Evoke Pharma, Inc. (NASDAQ:EVOK) Short Interest Update - Defense World
FY2025 Earnings Estimate for TSE:MNO Issued By Cormark - Defense World
Top Market Trend Impacting Digestive and Intestinal Remedies Development in the Coming Years:Technological ... - WhaTech
Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com - Defense World
Evoke Pharma stock hits 52-week low at $2.01 amid downturn By Investing.com - Investing.com South Africa
Evoke Pharma stock hits 52-week low at $2.01 amid downturn - Investing.com India
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2024 Earnings Call Transcript - MSN
StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World
US Reciprocal Tariffs Evoke Mixed Response From India Inc - Free Press Journal
Is The Market Punishing Lynch Group Holdings Limited (ASX:LGL) For Its Mixed Fundamentals? - AInvest
Gastroparesis Market Growth to Accelerate in Forecast Period - openPR.com
Evoke Pharma stock hits 52-week low at $2.43 amid challenges By Investing.com - Investing.com South Africa
Evoke Pharma stock hits 52-week low at $2.43 amid challenges - Investing.com India
Short Interest in Evoke Pharma, Inc. (NASDAQ:EVOK) Declines By 32.7% - Defense World
Tenaz Energy Corp. (OTCMKTS:ATUUF) Short Interest Update - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Evoke Pharma (NASDAQ:EVOK) Shares Cross Below 200 Day Moving Average – Here’s Why - Defense World
Evoke Pharma (NASDAQ:EVOK) Coverage Initiated at StockNews.com - Defense World
Bleichroeder LP Significantly Reduces Stake in Evoke Pharma Inc - GuruFocus
Bleichroeder LP's Strategic Acquisition of Evoke Pharma Inc Shar - GuruFocus.com
Evoke Pharma stock hits 52-week low at $3.4 amid challenges - Investing.com Australia
Evoke Pharma stock hits 52-week low at $3.4 amid challenges By Investing.com - Investing.com South Africa
Market Cool On Evoke Pharma, Inc.'s (NASDAQ:EVOK) Revenues Pushing Shares 29% Lower - Simply Wall St
Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
EVOKEvoke Pharma Inc Latest Stock News & Market Updates - Stock Titan
Earnings call transcript: Evoke Pharma Q4 2024 reports strong sales growth - Investing.com Australia
Evoke Pharma’s Earnings Call Highlights Revenue Growth and Strategic Partnerships - TipRanks
Evoke Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Evoke Pharma Inc (EVOK) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans - Yahoo
Evoke Pharma Reports Strong Revenue Growth in 2024 - TipRanks
Evoke Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Marketscreener.com
EVOKE PHARMA Earnings Results: $EVOK Reports Quarterly Earnings - Nasdaq
Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
Arbor Realty Trust Closes a $1.15 Billion Repurchase Facility to Unwind Two Outstanding Collateralized Loan Obligations - The Manila Times
Evoke Pharma Doubles Revenue in 2024: Inside the Breakthrough Growth and Bold 2025 Forecast - StockTitan
Earnings Scheduled For March 13, 2025 - Benzinga
Gastroparesis Treatment Market Poised for Substantial Growth - openPR
Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025 - GlobeNewswire
Evoke Pharma, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025 - Nasdaq
When Will Evoke Pharma Share Its Latest Gimoti Sales Numbers? - StockTitan
Evoke Pharma (EVOK) to Release Quarterly Earnings on Wednesday - Defense World
Sanctuary Advisors LLC Sells 40,570 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) - Defense World
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Sold by Sanctuary Advisors LLC - Defense World
0.47%
0.69%
자본화:
|
볼륨(24시간):